After signing agreements to use computing power from Nvidia, AMD and Oracle, OpenAI is teaming up with the world’s largest cloud computing company. By Cade Metz Many corporate interests that have ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...